Dow Jones Falls as JPMorgan Earnings Weigh
The major averages closed broadly lower, with JPMorgan bogging down the Dow as investors digested its earnings as well as new data, including the U.S. consumer price index. The release may be seen helping to shape expectations for Federal Reserve policy and the pace of potential rate cuts later this year. The annual inflation rate remained stable at 2.7%, while the core annual rate also remained at 2.6%, the lowest since 2021.Looking to commodities, gold edged lower as the "safe haven" asset retreats from record highs. Oil was surging ahead of this afternoon's API crude numbers release.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:JPMorganreportedand provided its outlook for FY26Deltareportedand revenue and provided guidance for Q1 and FY26L3Harrisannounced the creation of a, adding that it will pursue an IPO of the unit in 2H26Boeingreported 600in FY25Microsoftannounced a 5-point-plan foras Trump lauded the company amid criticism of utility bill increases amid data center builds2. WALL STREET CALLS:Intelto Overweight at KeyBancAMDto Overweight at KeyBancArmto Neutral at BofACharterto Underweight at Wells FargoMGM Resortsto Hold at Truist3. AROUND THE WEB:Venezuela's PDVSA has started to reverse oil production cuts, Reuters reportsBlackRockplans to cut hundreds of jobs as part of a regular round of layoffs to improve efficiency, Reuters reportsApple'sservices business continues to be a major profit engine, delivering record results in 2025 and entering 2026 with a focus on innovation, privacy, and customer experience, The Hollywood Reporter saysGoogleremoved AI Overviews for two liver health queries after experts warned of "alarming" results, but slight tweaks still trigger AI responses, Guardian reportsUBSCEO Sergio Ermotti plans to step down in April 2027, FT says4. MOVERS:Lithium Argentinahigher in New York after Deutsche Bankthe stock to BuyHIVE Digitalincreases after announcing itsArcus Biosciencesgains after Goldman Sachsthe stock to BuyTravere Therapeuticslower after theof the clinical benefit of FILSPARIWealthfrontfalls after5. EARNINGS/GUIDANCEIlluminafor Q4 and FY25Concentrixand provided guidance for Q1 and FY26Sight Sciencesreported, with CEO Paul Badawi commenting, "We are pleased with our progress in the fourth quarter"BNY Mellonwith EPS and revenue beating consensusCardinal Healthfor FY26INDEXES:The Dow fell 398.21, or 0.80%, to 49,191.99, the Nasdaq lost 24.03, or 0.10%, to 23,709.87, and the S&P 500 declined 13.53, or 0.19%, to 6,963.74.
Analyst Views on BP
About BP
About the author






